Dr. Hamideh Parhiz's lab focuses on developing innovative nanotechnology to improve drug delivery for treating acute respiratory distress syndrome (ARDS). Through the use of lipid nanoparticles that can deliver modified mRNA, the lab aims to target specific lung cells to enhance therapeutic outcomes. Their research is particularly relevant given the rising incidence of ARDS and aims to provide new treatment avenues to reduce mortality rates.

David M Allman's lab at the University of Pennsylvania focuses on understanding the survival mechanisms of plasma cells, which are crucial for producing antibodies in the immune system. They study how these cells adapt to their environments and resist therapies, particularly in diseases like multiple myeloma and during organ transplantation. The lab utilizes advanced techniques to explore the molecular pathways involved in plasma cell longevity and how they can be targeted for therapeutic interventions.

Dr. Michael Platt's lab focuses on understanding how environmental stressors, like natural disasters, affect mental health and social behavior. Using the unique situation of free-ranging rhesus macaques impacted by a hurricane, the lab investigates the biological and social factors that contribute to resilience or vulnerability in response to stress. The findings could have important implications for improving mental health outcomes in humans by identifying protective factors from social connections.

Dr. Daniel J. Powell's lab focuses on developing advanced CAR T cell therapies for treating solid tumors, particularly ovarian cancer. Their innovative approach combines gene-engineered T cells with imaging techniques to monitor treatment effectiveness and adjust therapies as needed. This multidisciplinary effort aims to leverage the body's immune system to effectively target cancer cells while minimizing toxic side effects.

Dr. Austin Pantel's lab focuses on advancing cancer imaging techniques using innovative PET radiotracers. They develop methods to conduct dual-tracer imaging in a single session, which allows for more efficient and accurate cancer diagnosis and monitoring. This work aims to improve precision medicine in oncology and better inform treatment decisions for patients.

Dr. Ravi Radhakrishnan's lab at the University of Pennsylvania investigates how cancer cells communicate with their environment to promote the spread of tumors, especially in aggressive types like triple-negative breast cancer. The research focuses on small vesicles called exosomes that cancer cells use to suppress the immune system and help tumors grow and spread in the body. By studying the physical properties of the tumor environment, such as stiffness, the lab aims to uncover new ways to combat cancer progression and enhance the effectiveness of cancer immunotherapies.

Dr. Arjun Raj's lab focuses on understanding how the intestinal epithelium, which lines the gut, organizes itself at a cellular level. By studying the interactions between cells using advanced technologies, the lab aims to uncover the principles of self-organization and regeneration. This research has important implications for improving tissue repair in diseases affecting the gut.

Dr. Ravinder Reddy's lab at the University of Pennsylvania focuses on understanding muscle metabolism and the role of NAD+ in human health. The lab is pioneering non-invasive imaging techniques to study how muscles generate energy, especially as we age. They aim to develop better methods for measuring important metabolites like NAD+, which could lead to new treatments for various diseases related to muscle function and metabolism.

Dr. Rahim R Rizi's lab focuses on advancing imaging techniques to evaluate lung health and improve treatments for lung diseases. The research aims to make lung transplants safer and more effective and to develop non-invasive imaging methods that assess lung function in real time, even in patients who normally can't perform lung function tests. They also explore treatments for conditions like emphysema, aiming to enhance patient outcomes.

Guo-Li Ming's lab at the University of Pennsylvania focuses on understanding how RNA modifications affect the brain's development and function. This research looks into the roles of various RNA modifications, particularly in relation to neurological disorders. By employing advanced techniques such as stem cell models, the lab aims to uncover the impact of these modifications on brain physiology and diseases like obesity and microcephaly.

Dr. Patrick Seale's lab focuses on understanding how fat tissue changes during obesity and the impact this has on health. They study specific cells in fat tissue called mesenchymal progenitor cells, which can switch their roles and promote inflammation when the body is under stress from excess weight. This research is crucial for finding new ways to treat obesity-related diseases like diabetes and heart disease.

Dr. Frances E. Jensen's lab at the University of Pennsylvania focuses on understanding how seizures affect brain function and contribute to diseases like Alzheimer's. The research explores the relationship between seizure activity in early life and its effects on cognitive abilities and synaptic connections throughout life. By studying animal models and human brain tissue, the lab aims to find new ways to treat or prevent cognitive decline associated with seizures and neurodegenerative diseases.

Dr. Sunny Shin's lab at the University of Pennsylvania studies the immune system's responses to bacterial infections, particularly those caused by gram-negative bacteria. The lab focuses on how specific immune responses, called inflammasomes, are triggered by a component of bacteria known as lipopolysaccharide (LPS). Understanding these responses can lead to new treatments for severe infections and sepsis, a serious condition that can result from overwhelming immune reactions.

Dr. James Shorter's lab at the University of Pennsylvania is focused on developing innovative RNA-based therapies to combat neurodegenerative diseases like Alzheimer's and ALS. Their research explores how short RNA molecules can prevent harmful changes in a protein called TDP-43, which is involved in many neurodegenerative disorders. By understanding and manipulating the behavior of TDP-43, they aim to create effective treatments that restore normal protein function and protect neurons from degeneration.

The lab led by Dr. Phillip Scott at the University of Pennsylvania focuses on the relationship between the skin microbiome and cutaneous leishmaniasis, a neglected tropical disease that results in severe skin lesions. They investigate how specific bacteria, like Staphylococcus aureus, contribute to disease severity, aiming to develop new therapies that target host immune responses. Additionally, the lab studies resident memory T cells in the skin to better understand how to enhance immunity against leishmaniasis and other diseases transmitted by vectors.

Dr. Taku Kambayashi's lab at the University of Pennsylvania studies how the skin microbiome interacts with immune cells to regulate the secretion of sebum, an oily substance that helps maintain skin barrier functions. The lab investigates the immune-sebum axis, focusing on communication between immune cells and skin microorganisms. They aim to understand how these interactions influence skin health and protect against infections.

Dr. Nancy Speck's lab focuses on understanding how a gene called RUNX1 influences inflammation in blood cells, particularly in patients who have mutations that can lead to blood cancers. Her research aims to uncover how these mutations affect immune responses, potentially contributing to cancer development. By studying both human patients and mouse models, the lab seeks to find ways to reduce harmful inflammation linked to these genetic changes.

The research lab led by Edward Steager focuses on creating innovative robotic systems for improving dental treatments, particularly in managing infections caused by oral biofilms. Using nanotechnology, the lab designs small robots that can precisely target and disrupt biofilms in hard-to-reach areas of the mouth, offering a potential breakthrough in dental medicine. The project aims to enhance the efficacy of dental procedures by combining robotics and biochemistry for better diagnostics and treatment.

Dr. Zhaolan Zhou's lab at the University of Pennsylvania focuses on understanding how chronic stress can make individuals more vulnerable to mental health disorders like depression. The lab uses mouse models to study the genetic and epigenetic mechanisms behind this vulnerability, specifically looking at how specific proteins in the brain respond to stress. Their work aims to uncover the biological changes caused by stress that lead to unusual behaviors, with the goal of improving diagnosis and treatment options for psychiatric conditions.

Dr. Shinjae Chung's lab at the University of Pennsylvania investigates how stress affects sleep patterns and cognitive function. They study the neural circuits involved in sleep regulation and how disturbances in sleep due to stress can lead to memory issues and affect mental health. The ultimate goal is to uncover insights that could lead to new therapies for sleep disorders triggered by stress.